Radio and PodcastRadio and PodcastLive Radio & Podcasts
Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy artwork
Science & Medicine

Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy

JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer by American Medical Association

Jan 30, 202511:55Science & Medicine

Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy. Hosted by Vivek Subbiah, MD. Related Content: Intracr...

About This Episode

Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy is an episode from JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer by Ame...

Podcast

This episode belongs to JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jan 30, 2025, 11:55 long, audio available.

Related Episodes

Continue listening to more episodes from JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer.

Questions About This Episode

What is Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy about?

Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy. Hosted by Vivek Subbiah, MD. Related Content: Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy

Where can I listen to Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy?

You can listen to Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy online on Radio and Podcast. Open the player on this page to stream the available audio.

Which podcast is Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy from?

Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy is an episode from JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer by American Medical Association.

How long is this episode?

This episode is 11:55 long.

When was this episode published?

This episode was published on Jan 30, 2025.

Can I save Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy for later?

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Are there related episodes from JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer?

Yes. This page shows related episodes from JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer when more episodes are available from the podcast feed.

Quick Answers About This Episode

Where can I listen to Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy?

You can listen to Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy on this page when the episode audio is available from the podcast feed.

Which podcast is this episode from?

Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy is from JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer by American Medical Association.

What are the episode details?

Published Jan 30, 2025 and 11:55 long